Mechanism of escape from nonsense-mediated mRNA decay of human β-globin transcripts with nonsense mutations in the first exon

  1. Andreas E. Kulozik1,2
  1. 1Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, 69120 Heidelberg, Germany
  2. 2Molecular Medicine Partnership Unit, University of Heidelberg and European Molecular Biology Laboratory, 69120 Heidelberg, Germany
  3. 3European Molecular Biology Laboratory, 69117 Heidelberg, Germany
  • 4 Present address: Institute for Genetics, University of Köln, 50674 Köln, Germany.

  • 5 Present address: Clinic of Psychiatry, Charité CBF, 14050 Berlin, Germany.

  • 6 Present address: Department of Pediatrics, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.

Abstract

The degradation of nonsense-mutated β-globin mRNA by nonsense-mediated mRNA decay (NMD) limits the synthesis of C-terminally truncated dominant negative β-globin chains and thus protects the majority of heterozygotes from symptomatic β-thalassemia. β-globin mRNAs with nonsense mutations in the first exon are known to bypass NMD, although current mechanistic models predict that such mutations should activate NMD. A systematic analysis of this enigma reveals that (1) β-globin exon 1 is bisected by a sharp border that separates NMD-activating from NMD-bypassing nonsense mutations and (2) the ability to bypass NMD depends on the ability to reinitiate translation at a downstream start codon. The data presented here thus reconcile the current mechanistic understanding of NMD with the observed failure of a class of nonsense mutations to activate this important mRNA quality-control pathway. Furthermore, our data uncover a reason why the position of a nonsense mutation alone does not suffice to predict the fate of the affected mRNA and its effect on protein expression.

Keywords

Footnotes

  • Reprint requests to: Andreas E. Kulozik, Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, 69120 Heidelberg, Germany; e-mail: Andreas.Kulozik{at}med.uni-heidelberg.de; or Matthias W. Hentze, Molecular Medicine Partnership Unit, University of Heidelberg and European Molecular Biology Laboratory, Im Neuenheimer Feld 156, 69120 Heidelberg, Germany; e-mail: hentze{at}embl.de; fax: 49 6221 564580.

  • Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.2401811.

  • Received August 2, 2010.
  • Accepted January 31, 2011.

Freely available online through the RNA Open Access option.

| Table of Contents
OPEN ACCESS ARTICLE